Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12620000458932
Ethics application status
Approved
Date submitted
10/03/2020
Date registered
8/04/2020
Date last updated
21/04/2024
Date data sharing statement initially provided
8/04/2020
Type of registration
Prospectively registered
Titles & IDs
Public title
Australian MRI-Linac Patient Imaging Trial
Query!
Scientific title
Establishing imaging and treatment workflows for the treatment of difference cancer sites on the Australian MRI-Linac - A pilot study.
Query!
Secondary ID [1]
300758
0
Nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
AMPI
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Cancer requiring radiation therapy treatment
316607
0
Query!
Condition category
Condition code
Cancer
314836
314836
0
0
Query!
Any cancer
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Eligible patients will receive two additional MRI scan sessions on the Australian MRI Linac. Each scan will take no more than one hour and separated by approximately 1 week from each other, depending on their treatment plan and other standard medical appointments they may have within the hospital. The imaging sessions will be conducted by MRI trained staff with qualified Radiation Therapist, Radiation Oncologist and Medical Physicist to assist where required. MRI gadolinium contrast may be given at MRI simulation during the scan if clinically indicated for the patients tumour site. The dose will be according to department standard practices.
Query!
Intervention code [1]
317088
0
Treatment: Devices
Query!
Comparator / control treatment
No control group
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
323188
0
To qualitatively assess the imaging acquired by the Australian MRI-Linac. A range of cancer sites will be examined and the quality of the MRI-Linac images will be assessed. The research team inclusive of a Radiation Oncologist, physicist, radiographer and radiation therapist will assess images and complete an evaluation form.
Query!
Assessment method [1]
323188
0
Query!
Timepoint [1]
323188
0
After each participant's second imaging session on the MRI-Linac.
Query!
Secondary outcome [1]
381408
0
Patient comfort and satisfaction will be assessed with using a Patient Satisfaction and comfort questionnaire. This is a composite outcome. The patient satisfaction and comfort questionnaire has been designed specifically for this study focusing on the the use of the Australian MRI-Linac. The questionnaire is titled 'Australian MRI-Linac Patient Experience Questionnaire'
Query!
Assessment method [1]
381408
0
Query!
Timepoint [1]
381408
0
After each scanning session on the MRI-Linac.
Query!
Eligibility
Key inclusion criteria
18 years or older
Have the ability to give informed consent with the clear understanding that this is a prototype cancer radiation therapy system and not a commercially available and supported system
Undergoing radiotherapy treatment at Liverpool or Macarthur Cancer Therapy Centres
Patients presenting with the following tumour treatment sites but not limited to: Bone metastases, Breast cancer, CNS cancer (including glioma, brain metastases), Gastrointestinal cancer (including pancreatic, liver, oesophageal and rectal cancer), Gynaecological cancer (including cervix),Head and neck cancer, Lung cancer, Prostate cancer, Renal cancer,
ECOG status 0-2
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Pain or discomfort in MRI-Linac simulation positions.
Patient unable to physically fit into the MRI-Linac patient treatment space or MRI Simulator
Contraindication to standard radiation therapy
Contraindicated for MRI as according to departmental policy.
Pregnant women
Query!
Study design
Purpose of the study
Educational / counselling / training
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
For each disease treatment site, imaging, patient setup and workflows will be developed based on the acquired images and patient feedback data. Workflows will be assessed by clinical staff for acceptability based on standard of care.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
13/04/2020
Query!
Actual
21/05/2021
Query!
Date of last participant enrolment
Anticipated
1/04/2025
Query!
Actual
Query!
Date of last data collection
Anticipated
1/12/2025
Query!
Actual
Query!
Sample size
Target
100
Query!
Accrual to date
8
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
16105
0
Liverpool Hospital - Liverpool
Query!
Recruitment hospital [2]
16106
0
Campbelltown Hospital - Campbelltown
Query!
Recruitment hospital [3]
16107
0
Bankstown-Lidcombe Hospital - Bankstown
Query!
Recruitment postcode(s) [1]
29620
0
2170 - Liverpool
Query!
Recruitment postcode(s) [2]
29621
0
2560 - Campbelltown
Query!
Recruitment postcode(s) [3]
29622
0
2200 - Bankstown
Query!
Funding & Sponsors
Funding source category [1]
305218
0
Government body
Query!
Name [1]
305218
0
National Health and Medical Research Council
Query!
Address [1]
305218
0
National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601
Query!
Country [1]
305218
0
Australia
Query!
Primary sponsor type
Government body
Query!
Name
South Western Sydney Local Health District
Query!
Address
Cnr of Goulburn and Elizabeth Streets, Liverpool Hospital, Liverpool, NSW 2170
Query!
Country
Australia
Query!
Secondary sponsor category [1]
305577
0
None
Query!
Name [1]
305577
0
Query!
Address [1]
305577
0
Query!
Country [1]
305577
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
305566
0
South Western Sydney Local Health District
Query!
Ethics committee address [1]
305566
0
Cnr of Goulburn and Elizabeth Streets, Liverpool, NSW 2170
Query!
Ethics committee country [1]
305566
0
Australia
Query!
Date submitted for ethics approval [1]
305566
0
14/01/2020
Query!
Approval date [1]
305566
0
10/03/2020
Query!
Ethics approval number [1]
305566
0
Query!
Summary
Brief summary
The purpose of this study is to try out a new imaging machine, called Integrated Magnetic Resonance Imaging Linear Accelerators (MRI-Linacs) Who is it for? You may be eligible for this study if you are aged 18 years or older and are undergoing radiation therapy for cancer at Liverpool or Macarthur Cancer Therapy Centres in Sydney. Study details All participants in this study will have two MRI-Linacs scans. The scans will be about a week apart, and involve lying still on on different positions depending on site of treatment within a confined doughnut like machine. In addition to the scans, participants will also answer questionnaires, consent to access medical records, You may require a dye injected through your viens to enhance image quality depending on the area you are having treatment to. It is hoped this research will provide information to develop new imaging procedures on the Australian MRI-Linac. The data collected will be critical in developing future MRI Linac treatments on this device.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
100794
0
Dr Trang Pham
Query!
Address
100794
0
Ingham Institute, 1 Campbell St, Liverpool NSW 2170
Query!
Country
100794
0
Australia
Query!
Phone
100794
0
+61 2 87389148
Query!
Fax
100794
0
+61 2 87389205
Query!
Email
100794
0
[email protected]
Query!
Contact person for public queries
Name
100795
0
Penny Phan
Query!
Address
100795
0
Ingham Institute. 1 Campbell St, Liverpool NSW 2170
Query!
Country
100795
0
Australia
Query!
Phone
100795
0
+61 2 87389148
Query!
Fax
100795
0
+61 2 87389205
Query!
Email
100795
0
[email protected]
Query!
Contact person for scientific queries
Name
100796
0
Trang Pham
Query!
Address
100796
0
Ingham Institute, 1 Campbell St, Liverpool NSW 2170
Query!
Country
100796
0
Australia
Query!
Phone
100796
0
+61 2 87389148
Query!
Fax
100796
0
+61 2 87389205
Query!
Email
100796
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Data will be analysed as a cohort and trends will be analysed.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF